5th Circ. Unwinds Cassava Class Over 'Meme Stock' Claims
The Fifth Circuit has overturned the class status of investors accusing Cassava Sciences Inc. of making misleading statements about clinical trial results for a potential Alzheimer's drug, saying that a lower...To view the full article, register now.
Already a subscriber? Click here to view full article